International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis (Q33784003)

29 July 2017

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis (English)

1 reference

Karl-Hermann Meyer zum Büschenfelde

29 July 2017

0 references

1 reference

24

object named as

Meyer zum Büschenfelde KH

1 reference

29 July 2017

Alvarez F

1

1 reference

29 July 2017

Berg PA

2

1 reference

29 July 2017

Bianchi FB

3

1 reference

29 July 2017

Bianchi L

4

1 reference

29 July 2017

Burroughs AK

5

1 reference

29 July 2017

Cancado EL

6

1 reference

29 July 2017

Chapman RW

7

1 reference

29 July 2017

Cooksley WG

8

1 reference

29 July 2017

Czaja AJ

9

1 reference

29 July 2017

Desmet VJ

10

1 reference

29 July 2017

Donaldson PT

11

1 reference

29 July 2017

Eddleston AL

12

1 reference

29 July 2017

Fainboim L

13

1 reference

29 July 2017

Heathcote J

14

1 reference

29 July 2017

Homberg JC

15

1 reference

29 July 2017

Hoofnagle JH

16

1 reference

29 July 2017

Kakumu S

17

1 reference

29 July 2017

Krawitt EL

18

1 reference

29 July 2017

Mackay IR

19

1 reference

29 July 2017

MacSween RN

20

1 reference

29 July 2017

Maddrey WC

21

1 reference

29 July 2017

Manns MP

22

1 reference

29 July 2017

McFarlane IG

23

1 reference

29 July 2017

Zeniya M

25

1 reference

29 July 2017

1 November 1999

1 reference

29 July 2017

Journal of Hepatology

1 reference

29 July 2017

31

1 reference

29 July 2017

5

1 reference

29 July 2017

929-938

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Validation of scoring system for diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

The international autoimmune hepatitis score in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Natural history, clinical features, and treatment of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Subfulminant hepatic failure in autoimmune hepatitis type 1: an unusual form of presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Type I autoimmune hepatitis is primarily a disease of later life

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

How to diagnose autoimmune hepatitis in systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Anti-cytoskeletal autoantibodies: diagnostic significance for liver diseases, infections and systemic autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Autoantibodies against nuclear envelope proteins in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Autoimmune hepatitis in childhood: a 20-year experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

How many types of autoimmune hepatitis are there?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

GBV-C/HGV is not the major cause of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Immunologic features and HLA associations in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

PBC and AMA--what is the connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Natural history of early primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Primary sclerosing cholangitis with normal serum alkaline phosphatase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

A 39 year old man with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

A 28-year-old woman with a combined hepatitic/cholestatic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980297-9

7 January 2021

10.1016/S0168-8278(99)80297-9

Identifiers

DOI

1 reference

29 July 2017

1 reference